Protective Effects of N-Acetylcysteine in Concanavalin A-Induced Hepatitis in Mice

This study was designed to study the protective effects and mechanisms of N-acetylcysteine (NAC) in concanavalin A-induced hepatitis in mice. In this study, pretreatment with NAC ameliorated the histopathological changes and suppressed inflammatory cytokines in ConA-induced hepatitis. The expression...

Full description

Bibliographic Details
Main Authors: Chengfen Wang, Yujing Xia, Yuanyuan Zheng, Weiqi Dai, Fan Wang, Kan Chen, Jingjing Li, Sainan Li, Rong Zhu, Jing Yang, Qin Yin, Huawei Zhang, Junshan Wang, Jie Lu, Yingqun Zhou, Chuanyong Guo
Format: Article
Language:English
Published: Hindawi Limited 2015-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2015/189785
id doaj-a117c3374fa94e15a10bbc2a239974c6
record_format Article
spelling doaj-a117c3374fa94e15a10bbc2a239974c62020-11-24T21:00:02ZengHindawi LimitedMediators of Inflammation0962-93511466-18612015-01-01201510.1155/2015/189785189785Protective Effects of N-Acetylcysteine in Concanavalin A-Induced Hepatitis in MiceChengfen Wang0Yujing Xia1Yuanyuan Zheng2Weiqi Dai3Fan Wang4Kan Chen5Jingjing Li6Sainan Li7Rong Zhu8Jing Yang9Qin Yin10Huawei Zhang11Junshan Wang12Jie Lu13Yingqun Zhou14Chuanyong Guo15Department of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University of Medicine, Shanghai 200072, ChinaDepartment of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University of Medicine, Shanghai 200072, ChinaDepartment of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University of Medicine, Shanghai 200072, ChinaDepartment of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University of Medicine, Shanghai 200072, ChinaDepartment of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University of Medicine, Shanghai 200072, ChinaDepartment of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University of Medicine, Shanghai 200072, ChinaDepartment of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University of Medicine, Shanghai 200072, ChinaDepartment of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University of Medicine, Shanghai 200072, ChinaDepartment of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University of Medicine, Shanghai 200072, ChinaDepartment of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University of Medicine, Shanghai 200072, ChinaDepartment of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University of Medicine, Shanghai 200072, ChinaDepartment of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University of Medicine, Shanghai 200072, ChinaDepartment of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University of Medicine, Shanghai 200072, ChinaDepartment of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University of Medicine, Shanghai 200072, ChinaDepartment of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University of Medicine, Shanghai 200072, ChinaDepartment of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University of Medicine, Shanghai 200072, ChinaThis study was designed to study the protective effects and mechanisms of N-acetylcysteine (NAC) in concanavalin A-induced hepatitis in mice. In this study, pretreatment with NAC ameliorated the histopathological changes and suppressed inflammatory cytokines in ConA-induced hepatitis. The expression of IL-2, IL-6, TNF-α, and IFN-γ was significantly reduced in the NAC-treated groups. NAC activated PI3K/Akt pathway and inhibited the activation of NF-κB. Additionally, NAC reduced autophagosome formation, as assessed by detecting the expression of LC3 and Beclin 1. Our results demonstrate that NAC can alleviate ConA-induced hepatitis by regulating the PI3K/Akt pathway and reducing the late stages of autophagy. Our results described a new pharmaceutical to provide more effective therapies for immune hepatitis.http://dx.doi.org/10.1155/2015/189785
collection DOAJ
language English
format Article
sources DOAJ
author Chengfen Wang
Yujing Xia
Yuanyuan Zheng
Weiqi Dai
Fan Wang
Kan Chen
Jingjing Li
Sainan Li
Rong Zhu
Jing Yang
Qin Yin
Huawei Zhang
Junshan Wang
Jie Lu
Yingqun Zhou
Chuanyong Guo
spellingShingle Chengfen Wang
Yujing Xia
Yuanyuan Zheng
Weiqi Dai
Fan Wang
Kan Chen
Jingjing Li
Sainan Li
Rong Zhu
Jing Yang
Qin Yin
Huawei Zhang
Junshan Wang
Jie Lu
Yingqun Zhou
Chuanyong Guo
Protective Effects of N-Acetylcysteine in Concanavalin A-Induced Hepatitis in Mice
Mediators of Inflammation
author_facet Chengfen Wang
Yujing Xia
Yuanyuan Zheng
Weiqi Dai
Fan Wang
Kan Chen
Jingjing Li
Sainan Li
Rong Zhu
Jing Yang
Qin Yin
Huawei Zhang
Junshan Wang
Jie Lu
Yingqun Zhou
Chuanyong Guo
author_sort Chengfen Wang
title Protective Effects of N-Acetylcysteine in Concanavalin A-Induced Hepatitis in Mice
title_short Protective Effects of N-Acetylcysteine in Concanavalin A-Induced Hepatitis in Mice
title_full Protective Effects of N-Acetylcysteine in Concanavalin A-Induced Hepatitis in Mice
title_fullStr Protective Effects of N-Acetylcysteine in Concanavalin A-Induced Hepatitis in Mice
title_full_unstemmed Protective Effects of N-Acetylcysteine in Concanavalin A-Induced Hepatitis in Mice
title_sort protective effects of n-acetylcysteine in concanavalin a-induced hepatitis in mice
publisher Hindawi Limited
series Mediators of Inflammation
issn 0962-9351
1466-1861
publishDate 2015-01-01
description This study was designed to study the protective effects and mechanisms of N-acetylcysteine (NAC) in concanavalin A-induced hepatitis in mice. In this study, pretreatment with NAC ameliorated the histopathological changes and suppressed inflammatory cytokines in ConA-induced hepatitis. The expression of IL-2, IL-6, TNF-α, and IFN-γ was significantly reduced in the NAC-treated groups. NAC activated PI3K/Akt pathway and inhibited the activation of NF-κB. Additionally, NAC reduced autophagosome formation, as assessed by detecting the expression of LC3 and Beclin 1. Our results demonstrate that NAC can alleviate ConA-induced hepatitis by regulating the PI3K/Akt pathway and reducing the late stages of autophagy. Our results described a new pharmaceutical to provide more effective therapies for immune hepatitis.
url http://dx.doi.org/10.1155/2015/189785
work_keys_str_mv AT chengfenwang protectiveeffectsofnacetylcysteineinconcanavalinainducedhepatitisinmice
AT yujingxia protectiveeffectsofnacetylcysteineinconcanavalinainducedhepatitisinmice
AT yuanyuanzheng protectiveeffectsofnacetylcysteineinconcanavalinainducedhepatitisinmice
AT weiqidai protectiveeffectsofnacetylcysteineinconcanavalinainducedhepatitisinmice
AT fanwang protectiveeffectsofnacetylcysteineinconcanavalinainducedhepatitisinmice
AT kanchen protectiveeffectsofnacetylcysteineinconcanavalinainducedhepatitisinmice
AT jingjingli protectiveeffectsofnacetylcysteineinconcanavalinainducedhepatitisinmice
AT sainanli protectiveeffectsofnacetylcysteineinconcanavalinainducedhepatitisinmice
AT rongzhu protectiveeffectsofnacetylcysteineinconcanavalinainducedhepatitisinmice
AT jingyang protectiveeffectsofnacetylcysteineinconcanavalinainducedhepatitisinmice
AT qinyin protectiveeffectsofnacetylcysteineinconcanavalinainducedhepatitisinmice
AT huaweizhang protectiveeffectsofnacetylcysteineinconcanavalinainducedhepatitisinmice
AT junshanwang protectiveeffectsofnacetylcysteineinconcanavalinainducedhepatitisinmice
AT jielu protectiveeffectsofnacetylcysteineinconcanavalinainducedhepatitisinmice
AT yingqunzhou protectiveeffectsofnacetylcysteineinconcanavalinainducedhepatitisinmice
AT chuanyongguo protectiveeffectsofnacetylcysteineinconcanavalinainducedhepatitisinmice
_version_ 1716780600357027840